learn about the symptoms of cancer diagnosed in Fabiana Justus

479

Content creator Fabiana Justus, 37, shared on her social media that she was diagnosed with acute myeloid leukemia (AML), a type of cancer that starts in the bone marrow. In a video taken from the hospital, the daughter of businessman Roberto Justus says that she discovered the disease after seeking medical help after feeling discomfort in her back and fever. She is hospitalized for the first phase of treatment against the disease.

• Running, weight training, cycling? Survey shows the favorite activity of healthy people
• Gen Z is aging faster: stress, fast food and a sedentary lifestyle may be the causes

What is acute myeloid leukemia?

Leukemia occurs when the bone marrow, the tissue inside our bones, begins to produce blood cells in an unbalanced and uncontrolled way. In other words, it starts to build immature and abnormal cells that take the place of other blood cells in the marrow, blood and lymphatic system.

There are four types of leukemia, with acute myeloid leukemia being the most common type of leukemia in adults. But even so, it is considered a rare cancer, especially in people under 45 years of age, like the influencer. The average age of patients with the disease is 68 years.

This type of cancer has this name because it affects myeloid cells, which give rise to leukocytes, platelets and red blood cells. The term “acute” indicates that this is an aggressive form of leukemia in which diseased cells multiply rapidly.

Symptoms of acute myeloid leukemia

The main symptoms of this type of cancer are:

• Fatigue;
• Tiredness;
• Shortness of breath during normal physical activities;
• Dizziness or fainting;
• Headaches;
• Pallor;
• Frequent infections;
• Fever;
• Hematomas;
• Red spots on the skin (petechiae);
• Bleeding;
• Loss of appetite;
• Weight loss for no apparent reason;
• Enlargement of the spleen and liver.

As it is a very aggressive disease, acute myeloid leukemia must be treated as soon as the diagnosis is made. Treatment varies according to the patient’s age, as well as cytogenetic and molecular risk factors. The options are: chemotherapy, targeted therapy and bone marrow transplant.